U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 55

1.
Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients
XUELEI WANG, LIQUN HUANG, XIAOFEI WEN, DONGYANG LI, GUOSHENG YANG, JUNHUA ZHENG
In Vivo. 2024 Jan-Feb; 38(1): 174–183. Published online 2024 Jan 3. doi: 10.21873/invivo.13423
PMCID:
PMC10756430
AbstractArticlePDF–2.5M
2.
Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia
Clinton O. Onyango, Qiuying Cheng, Elly O. Munde, Evans Raballah, Samuel B. Anyona, Benjamin H. McMahon, Christophe G. Lambert, Patrick O. Onyango, Kristan A. Schneider, Douglas J. Perkins, Collins Ouma
BMC Genomics. 2023; 24: 542. Published online 2023 Sep 13. doi: 10.1186/s12864-023-09565-1
PMCID:
PMC10498606
AbstractArticlePDF–1.1M
3.
Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells
R Xing, L Li, L Chen, Z Gao, H Wang, W Li, J Cui, G Tian, Q Liang, J Yu, JJ Sung, G Luo, H Gao, X Xu, H Yang, J Wang, X Zhang, JM Wang, J Huang, Y Yu, J Wang, Y Lu
Oncogene. Author manuscript; available in PMC 2020 Sep 24.
Published in final edited form as: Oncogene. 2016 May 19; 35(20): 2584–2591. Published online 2015 Sep 14. doi: 10.1038/onc.2015.324
PMCID:
PMC7512012
AbstractArticlePDF–2.0M
4.
Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
Gabriel Andrade Nonato Queiroz, Rita Elizabeth Moreira Mascarenhas, Vincent Vieillard, Raphaela Lisboa Andrade, Bernardo Galvão-Castro, Maria Fernanda Rios Grassi
BMC Infect Dis. 2019; 19: 433. Published online 2019 May 17. doi: 10.1186/s12879-019-4032-1
PMCID:
PMC6525417
AbstractArticlePDF–2.3M
5.
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, Jaba Gamrekelashvili, Fei Zhao, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Tim F. Greten, Firouzeh Korangy
Hepatology. Author manuscript; available in PMC 2019 Feb 1.
Published in final edited form as: Hepatology. 2009 Sep; 50(3): 799–807. doi: 10.1002/hep.23054
PMCID:
PMC6357774
AbstractArticlePDF–2.0M
6.
Beyond genome-wide scan: Association of a cis-regulatory NCR3 variant with mild malaria in a population living in the Republic of Congo
Sabrina Baaklini, Sarwat Afridi, Thy Ngoc Nguyen, Felix Koukouikila-Koussounda, Mathieu Ndounga, Jean Imbert, Magali Torres, Lydie Pradel, Francine Ntoumi, Pascal Rihet
PLoS One. 2017; 12(11): e0187818. Published online 2017 Nov 9. doi: 10.1371/journal.pone.0187818
PMCID:
PMC5679660
AbstractArticlePDF–1.8M
7.
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, Jerome Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Samuel Granjeaud, Clemence Demerle, Jean-François Hamel, Adelheid Cerwenka, Elke Pogge von Strandmann, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet-Lefebvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Daniel Olive
Oncotarget. 2017 Jul 25; 8(30): 49548–49563. Published online 2017 May 10. doi: 10.18632/oncotarget.17747
Correction in:
Oncotarget. 2019 Sep 10; 10(52): 5493.
PMCID:
PMC5564787
AbstractArticlePDF–5.5M
8.
NKp30 isoforms in patients with chronic hepatitis C virus infection
Stefania Mantovani, Dalila Mele, Barbara Oliviero, Giorgio Barbarini, Stefania Varchetta, Mario U Mondelli
Immunology. 2015 Oct; 146(2): 234–242. Published online 2015 Jul 8. doi: 10.1111/imm.12495
PMCID:
PMC4582964
AbstractArticlePDF–682K
9.
NCR3/NKp30 contributes to pathogenesis in primary Sjögren’s syndrome
Sylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, Michaela Semeraro, Caroline Flament, Sophie Caillat-Zucman, Damien Sène, Nicolas Delahaye, Eric Vivier, Kariman Chaba1, Vichnou Poirier-Colame, Gunnel Nordmark, Maija-Leena Eloranta, Per Eriksson, Elke Theander, Helena Forsblad-d’Elia, Roald Omdal, Marie Wahren-Herlenius, Roland Jonsson, Lars Rönnblom, Joanne Nititham, Kimberly E. Taylor, Christopher J. Lessard, Kathy L. Moser Sivils, Jacques-Eric Gottenberg, Lindsey A. Criswell, Corinne Miceli-Richard, Laurence Zitvogel, Xavier Mariette
Sci Transl Med. Author manuscript; available in PMC 2014 Nov 19.
Published in final edited form as: Sci Transl Med. 2013 Jul 24; 5(195): 195ra96. doi: 10.1126/scitranslmed.3005727
PMCID:
PMC4237161
AbstractArticlePDF–2.0M
10.
Increased NK cytotoxicity and NKp30 expression protects against HCV infection in high-risk individuals and inhibits replication in vitro
Lucy Golden-Mason, Andrea L. Cox, Jessica A. Randall, Linling Cheng, Hugo R. Rosen
Hepatology. Author manuscript; available in PMC 2011 Nov 1.
Published in final edited form as: Hepatology. 2010 Nov; 52(5): 1581–1589. doi: 10.1002/hep.23896
PMCID:
PMC2967665
AbstractArticlePDF–1.8M
11.
Umbilical Cord Blood T cells Express Multiple Natural Cytotoxicity Receptors After IL-15 Stimulation, but Only NKp30 Is Functional
Qin Tang, Bartosz Grzywacz, Hongbo Wang, Nandini Kataria, Qing Cao, John E. Wagner, Bruce R. Blazar, Jeffrey S. Miller, Michael R. Verneris
J Immunol. Author manuscript; available in PMC 2009 Oct 1.
Published in final edited form as: J Immunol. 2008 Oct 1; 181(7): 4507–4515. doi: 10.4049/jimmunol.181.7.4507
PMCID:
PMC2614673
AbstractArticlePDF–1.9M
12.
Oral cancer cell-derived exosomes modulate natural killer cell activity by regulating the receptors on these cells
Xueqin Zhu, Xing Qin, Xiaoning Wang, Yingnan Wang, Wei Cao, Jianjun Zhang, Wantao Chen
Int J Mol Med. 2020 Dec; 46(6): 2115–2125. Published online 2020 Sep 24. doi: 10.3892/ijmm.2020.4736
PMCID:
PMC7595664
AbstractArticlePDF–1.9M
13.
Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1
Katherine Walwyn-Brown, Karolin Guldevall, Mezida Saeed, Daniela Pende, Björn Önfelt, Andrew S. MacDonald, Daniel M. Davis
J Immunol. 2018 Oct 1; 201(7): 2028–2041. Published online 2018 Aug 17. doi: 10.4049/jimmunol.1800475
PMCID:
PMC6139540
AbstractArticlePDF–1.9M
14.
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Sara Trabanelli, Mathieu F. Chevalier, Amaia Martinez-Usatorre, Alejandra Gomez-Cadena, Bérengère Salomé, Mariangela Lecciso, Valentina Salvestrini, Grégory Verdeil, Julien Racle, Cristina Papayannidis, Hideaki Morita, Irene Pizzitola, Camille Grandclément, Perrine Bohner, Elena Bruni, Mukul Girotra, Rani Pallavi, Paolo Falvo, Elisabeth Oppliger Leibundgut, Gabriela M. Baerlocher, Carmelo Carlo-Stella, Daniela Taurino, Armando Santoro, Orietta Spinelli, Alessandro Rambaldi, Emanuela Giarin, Giuseppe Basso, Cristina Tresoldi, Fabio Ciceri, David Gfeller, Cezmi A. Akdis, Luca Mazzarella, Saverio Minucci, Pier Giuseppe Pelicci, Emanuela Marcenaro, Andrew N. J. McKenzie, Dominique Vanhecke, George Coukos, Domenico Mavilio, Antonio Curti, Laurent Derré, Camilla Jandus
Nat Commun. 2017; 8: 593. Published online 2017 Sep 19. doi: 10.1038/s41467-017-00678-2
PMCID:
PMC5605498
AbstractArticlePDF–1.2M
15.
NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint
Avishai Shemesh, Aleksandra Kugel, Naama Steiner, Michal Yezersky, Dan Tirosh, Avishay Edri, Omri Teltsh, Benyamin Rosental, Eyal Sheiner, Eitan Rubin, Kerry S. Campbell, Angel Porgador
Oncotarget. 2016 Oct 25; 7(43): 70912–70923. Published online 2016 Sep 27. doi: 10.18632/oncotarget.12292
PMCID:
PMC5342598
AbstractArticlePDF–4.6M
16.
Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
Maryam Salimi, Luzheng Xue, Helen Jolin, Clare Hardman, David J. Cousins, Andrew N.J. McKenzie, Graham S. Ogg
J Immunol. Author manuscript; available in PMC 2016 Jul 1.
Published in final edited form as: J Immunol. 2016 Jan 1; 196(1): 45–54. Published online 2015 Nov 18. doi: 10.4049/jimmunol.1501102
PMCID:
PMC4913864
AbstractArticlePDF–1.5M
17.
Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
Wei Wang, Huaijian Guo, Jianlin Geng, Xiaodong Zheng, Haiming Wei, Rui Sun, Zhigang Tian
J Biol Chem. 2014 Nov 28; 289(48): 33311–33319. Published online 2014 Oct 14. doi: 10.1074/jbc.M114.603464
PMCID:
PMC4246088
AbstractArticlePDF–1.0M
18.
An NKp30-based chimeric antigen receptor promotes T-cell effector functions and anti-tumor efficacy in vivo
Tong Zhang, Ming-Ru Wu, Charles L. Sentman
J Immunol. Author manuscript; available in PMC 2013 Sep 1.
Published in final edited form as: J Immunol. 2012 Sep 1; 189(5): 2290–2299. Published online 2012 Jul 30. doi: 10.4049/jimmunol.1103495
PMCID:
PMC3633481
AbstractArticlePDF–1.2M
19.
Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
Yili Li, Qian Wang, Roy A. Mariuzza
J Exp Med. 2011 Apr 11; 208(4): 703–714. doi: 10.1084/jem.20102548
PMCID:
PMC3135353
AbstractArticlePDF–2.7M
20.
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt, Myriam Baratin, Eugene C. Yi, Jacob Kennedy, Zeren Gao, Brian Fox, Betty Haldeman, Craig D. Ostrander, Tomonori Kaifu, Christian Chabannon, Alessandro Moretta, Robert West, WenFeng Xu, Eric Vivier, Steven D. Levin
J Exp Med. 2009 Jul 6; 206(7): 1495–1503. doi: 10.1084/jem.20090681
PMCID:
PMC2715080
AbstractArticlePDF–4.0M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center